$2.32 Billion is the total value of HealthCor Management, L.P.'s 73 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 54.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $212,075,000 | +115.3% | 3,584,160 | +143.1% | 9.15% | +132.4% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $140,017,000 | +21.1% | 1,278,228 | +3.5% | 6.04% | +30.7% |
| BIIB | Buy | BIOGEN INC | $132,108,000 | +12.4% | 466,830 | +37.6% | 5.70% | +21.4% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $107,108,000 | +253.9% | 896,680 | +239.2% | 4.62% | +282.0% |
| WOOF | PETCO HEALTH & WELLNESS CO I | $104,328,000 | -5.8% | 4,944,450 | 0.0% | 4.50% | +1.6% | |
| NTRA | Buy | NATERA INC | $100,034,000 | +11.6% | 897,646 | +13.7% | 4.32% | +20.5% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $94,071,000 | +86.7% | 2,249,972 | +93.0% | 4.06% | +101.5% |
| MCK | Buy | MCKESSON CORP | $88,220,000 | +187.0% | 442,470 | +175.2% | 3.81% | +209.8% |
| MDT | Buy | MEDTRONIC PLC | $76,774,000 | +3.0% | 612,480 | +2.0% | 3.31% | +11.1% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $74,096,000 | +43.1% | 1,707,681 | +41.1% | 3.20% | +54.5% |
| THC | Buy | TENET HEALTHCARE CORP | $72,037,000 | +185.9% | 1,084,240 | +188.2% | 3.11% | +208.6% |
| NVRO | Buy | NEVRO CORP | $61,592,000 | -1.3% | 529,230 | +40.6% | 2.66% | +6.6% |
| CNC | New | CENTENE CORP DEL | $61,228,000 | – | 982,630 | +100.0% | 2.64% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $59,999,000 | – | 460,790 | +100.0% | 2.59% | – |
| SYK | Sell | STRYKER CORPORATION | $58,680,000 | -17.3% | 222,510 | -18.6% | 2.53% | -10.7% |
| HCA | Buy | HCA HEALTHCARE INC | $57,612,000 | +64.2% | 237,360 | +39.9% | 2.49% | +77.3% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $55,317,000 | +7.7% | 3,849,470 | +18.5% | 2.39% | +16.3% |
| LIVN | Buy | LIVANOVA PLC | $51,644,000 | +391.2% | 652,150 | +421.7% | 2.23% | +430.5% |
| WELL | Buy | WELLTOWER INC | $50,880,000 | +40.9% | 617,480 | +42.1% | 2.20% | +52.0% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $48,385,000 | -60.6% | 330,590 | -56.7% | 2.09% | -57.5% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $48,247,000 | +1.2% | 348,680 | +7.1% | 2.08% | +9.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $42,751,000 | +12.6% | 445,739 | +14.3% | 1.84% | +21.6% |
| CI | New | CIGNA CORP NEW | $42,390,000 | – | 211,780 | +100.0% | 1.83% | – |
| VTR | Buy | VENTAS INC | $40,028,000 | +43.2% | 725,010 | +48.1% | 1.73% | +54.5% |
| CANO | New | CANO HEALTH INC | $34,930,000 | – | 2,754,730 | +100.0% | 1.51% | – |
| BDX | New | BECTON DICKINSON & CO | $34,548,000 | – | 140,540 | +100.0% | 1.49% | – |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $31,096,000 | -57.2% | 46,730 | -60.7% | 1.34% | -53.7% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $23,633,000 | -0.6% | 130,290 | +10.5% | 1.02% | +7.3% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $23,212,000 | -22.8% | 1,214,670 | -30.6% | 1.00% | -16.6% |
| IDXX | Buy | IDEXX LABS INC | $22,264,000 | +17.9% | 35,800 | +19.7% | 0.96% | +27.3% |
| LGV | LONGVIEW ACQUISITION CORP II | $21,124,000 | +0.9% | 2,135,900 | 0.0% | 0.91% | +9.0% | |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $20,076,000 | -31.9% | 493,502 | -24.0% | 0.87% | -26.5% |
| INCY | INCYTE CORPcall | $18,364,000 | -18.2% | 267,000 | 0.0% | 0.79% | -11.8% | |
| ZTS | Sell | ZOETIS INCcl a | $16,125,000 | -62.2% | 83,060 | -63.8% | 0.70% | -59.2% |
| AFMD | Buy | AFFIMED N V | $15,796,000 | -23.3% | 2,555,908 | +5.5% | 0.68% | -17.1% |
| CYTK | Sell | CYTOKINETICS INC | $15,529,000 | +4.7% | 434,500 | -42.0% | 0.67% | +13.0% |
| CVS | Sell | CVS HEALTH CORP | $14,749,000 | -86.1% | 173,800 | -86.3% | 0.64% | -85.0% |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $13,123,000 | -7.2% | 386,190 | 0.0% | 0.57% | +0.2% | |
| RACB | RESEARCH ALLIANCE CORP II | $13,049,000 | -2.9% | 1,324,800 | 0.0% | 0.56% | +4.8% | |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $12,270,000 | -76.6% | 250,000 | -80.1% | 0.53% | -74.7% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $11,416,000 | +968.9% | 82,183 | +647.1% | 0.49% | +1046.5% |
| EHC | Sell | ENCOMPASS HEALTH CORP | $8,975,000 | -89.1% | 119,600 | -88.7% | 0.39% | -88.2% |
| FATE | New | FATE THERAPEUTICS INC | $7,613,000 | – | 128,450 | +100.0% | 0.33% | – |
| MSAC | MEDICUS SCIENCES ACQUISITION | $7,254,000 | +1.0% | 744,000 | 0.0% | 0.31% | +9.1% | |
| BNTX | New | BIONTECH SEsponsored ads | $6,467,000 | – | 23,690 | +100.0% | 0.28% | – |
| RAPT | Sell | RAPT THERAPEUTICS INC | $5,735,000 | -9.8% | 184,700 | -7.6% | 0.25% | -2.8% |
| OHPA | Sell | ORION ACQUISITION CORP | $5,310,000 | +0.4% | 547,385 | -0.0% | 0.23% | +8.5% |
| INCY | New | INCYTE CORP | $5,159,000 | – | 75,000 | +100.0% | 0.22% | – |
| New | ARYA SCIENCES ACQUISITN CORP | $4,940,000 | – | 500,000 | +100.0% | 0.21% | – | |
| LPTX | New | LEAP THERAPEUTICS INC | $4,812,000 | – | 1,200,000 | +100.0% | 0.21% | – |
| IKNA | Sell | IKENA ONCOLOGY INC | $4,290,000 | -19.1% | 339,951 | -10.0% | 0.18% | -12.7% |
| GHRS | Sell | GH RESEARCH PLCordinary shares | $3,638,000 | -33.0% | 164,912 | -34.0% | 0.16% | -27.6% |
| ABGI | ABG ACQUISITION CORP I | $3,208,000 | -0.6% | 329,400 | 0.0% | 0.14% | +7.0% | |
| OMEG | Sell | OMEGA ALPHA SPACcl a | $2,638,000 | -2.2% | 271,032 | -0.0% | 0.11% | +5.6% |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $2,622,000 | -2.4% | 262,150 | 0.0% | 0.11% | +5.6% | |
| RCUS | New | ARCUS BIOSCIENCES INC | $2,443,000 | – | 70,050 | +100.0% | 0.10% | – |
| VCYT | New | VERACYTE INC | $2,306,000 | – | 49,640 | +100.0% | 0.10% | – |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $2,321,000 | -2.8% | 234,180 | 0.0% | 0.10% | +5.3% | |
| RVNC | New | REVANCE THERAPEUTICS INC | $2,271,000 | – | 81,500 | +100.0% | 0.10% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $1,750,000 | – | 9,890 | +100.0% | 0.08% | – |
| MRUS | Sell | MERUS N V | $1,560,000 | -23.2% | 70,898 | -26.5% | 0.07% | -17.3% |
| New | PROCEPT BIOROBOTICS CORP | $1,427,000 | – | 37,400 | +100.0% | 0.06% | – | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $1,418,000 | – | 7,510 | +100.0% | 0.06% | – |
| New | DICE THERAPEUTICS INC | $1,402,000 | – | 42,800 | +100.0% | 0.06% | – | |
| JYAC | JIYA ACQUISITION CORP | $1,372,000 | -1.9% | 140,680 | 0.0% | 0.06% | +5.4% | |
| AVIR | New | ATEA PHARMACEUTICALS INC | $1,282,000 | – | 36,580 | +100.0% | 0.06% | – |
| JNJ | New | JOHNSON & JOHNSON | $1,176,000 | – | 7,280 | +100.0% | 0.05% | – |
| IMGN | New | IMMUNOGEN INC | $1,134,000 | – | 200,000 | +100.0% | 0.05% | – |
| ATAI | ATAI LIFE SCIENCES NV | $1,109,000 | -20.1% | 75,000 | 0.0% | 0.05% | -12.7% | |
| LGVWS | LONGVIEW ACQUISITION CORP II*w exp 99/99/999 | $551,000 | -5.8% | 427,178 | 0.0% | 0.02% | +4.3% | |
| CMLTW | CM LIFE SCIENCES III INC*w exp 04/30/202 | $214,000 | -17.1% | 99,998 | 0.0% | 0.01% | -10.0% | |
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $88,000 | -32.8% | 137,305 | 0.0% | 0.00% | -20.0% | |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $59,000 | -28.9% | 82,663 | 0.0% | 0.00% | 0.0% | |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -149,170 | -100.0% | -0.02% | – |
| ELEV | Exit | ELEVATION ONCOLOGY INC | $0 | – | -100,000 | -100.0% | -0.05% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -268,295 | -100.0% | -0.07% | – |
| GLUE | Exit | MONTE ROSA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.09% | – |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -103,717 | -100.0% | -0.09% | – |
| CYT | Exit | CYTEIR THERAPEUTICS INC | $0 | – | -120,000 | -100.0% | -0.10% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -41,080 | -100.0% | -0.11% | – |
| NVAX | Exit | NOVAVAX INCput | $0 | – | -23,500 | -100.0% | -0.20% | – |
| CMLT | Exit | CM LIFE SCIENCES III INC | $0 | – | -500,000 | -100.0% | -0.21% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -522,712 | -100.0% | -0.27% | – |
| ARYD | Exit | ARYA SCIENCES ACQU CORP IVcl a | $0 | – | -1,238,881 | -100.0% | -0.53% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -50,890 | -100.0% | -0.87% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -187,000 | -100.0% | -1.51% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -158,280 | -100.0% | -1.54% | – |
| VEEV | Exit | VEEVA SYS INC | $0 | – | -136,080 | -100.0% | -1.69% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -182,970 | -100.0% | -3.69% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -384,920 | -100.0% | -4.13% | – |
| HUM | Exit | HUMANA INC | $0 | – | -239,030 | -100.0% | -4.23% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -190,380 | -100.0% | -4.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.